ICD应用进展课件.ppt

* 34 * 35 * 阜外医院 张 澍 * 31 RV – High SVC Configuration * 阜外医院 张 澍 * 32 RV – SVC – SVC Configuration * 阜外医院 张 澍 * 33 RV – SVC – Sub-Q Patch Configuration * 阜外医院 张 澍 * 34 RV - SVC - Lateral Sub Q Patch * 阜外医院 张 澍 * 35 Epicardial System * * * * * * * * * * * Implant indications have changed dramatically from 1980, when patients actually had to survive two cardiac arrests. The current ACC/AHA/NASPE indications expanded the implant indications. Recent and ongoing studies, (MUSTT, MADIT, AVID, CABG Patch, and SCDHEFT), may increase the use of ICD technology in patients without the traditional history of sustained arrhythmias. MADIT was the first mulitcenter clinical trial to identify a therapeutic strategy with positive results for the high risk for sudden cardiac death post myocardial infarction patient group. In this study, prophylactic ICD therapy in a specifically defined patient group was associated with a significant reduction of all cause mortality [54%] when compared to conventional antiarrhythmic drug therapy. * It is estimated that only 30% of people in the US who meet Class I ACC/AHA indications receive an ICD. In other parts of the world, less than 10% of patients with these indications receive an ICD. * It is estimated that only 30% of people in the US who meet Class I ACC/AHA indications receive an ICD. In other parts of the world, less than 10% of patients with these indications receive an ICD. * It is estimated that only 30% of people in the US who meet Class I ACC/AHA indications receive an ICD. In other parts of the world, less than 10% of patients with these indications receive an ICD. * It is estimated that only 30% of people in the US who meet Class I ACC/AHA indications receive an ICD. In other parts of the world, less than 10% of patients with these indications receive an ICD. * There were no Class IIa ICD indications in this revision of the ACC/AHA guidelines. * * * 25 * 26 * 27 * 28 * 29 * 30 * 31 * 32 * 33 Check High Voltage